Skip to main content
Evidence-Ranked Guide

Best Peptides for Cognitive Performance

Semax and Selank lead a nootropic ranking backed by BDNF and stress-response research.

Nootropic peptides target neuroplasticity through BDNF, NGF and related growth-factor signalling. We ranked by catalogued cognitive evidence — Semax and Selank lead on clinical-tagged data — then by regulatory status and safety. Cerebrolysin is a prescription medication in some countries, while dihexa and P21 remain early-stage research compounds. None of these are approved in the US for cognitive enhancement.

The Ranked List

#1
SemaxResearch

ACTH analogue with clinical-tagged BDNF/NGF modulation — a 1.4-fold BDNF increase and 3-fold exon III BDNF mRNA — plus stroke-rehabilitation data; approved in Russia, research-only elsewhere.

Reported dose: 300–600 mcg 1–3×/day (intranasal)

Half-life: Extended

Route: Intranasal

Read the full Semax guide →
#2
SelankResearch

Anxiolytic peptide with clinical-tagged reductions in IL-1β, IL-6 and TNF-α under stress, across 26 catalogued benefits spanning anxiety, mood and cognition.

Reported dose: 200–400 mcg daily (intranasal)

Half-life: ~10 minutes

Route: Intranasal

Read the full Selank guide →
#3
CerebrolysinResearch

Neurotrophic peptide mixture researched for neuroplasticity and brain-injury recovery; a prescription medication in some countries.

Reported dose: 30 mL course over 10–21 days (IV)

Half-life: Variable

Route: IV

Read the full Cerebrolysin guide →
#4
DihexaResearch

HGF/c-Met pathway enhancer with a clinical-tagged synaptogenesis mechanism but minimal human data; its safety note flags it as extremely potent.

Reported dose: 2–10 mg daily (oral/SC)

Half-life: 12 hours

Route: Oral/SC

Read the full Dihexa guide →
#5
P21Research

CREB-pathway activator with preclinical-tagged enhanced neurogenesis in the dentate gyrus and increased BDNF expression.

Reported dose: 100–300 mcg daily

Half-life: Short

Route: SC/Intranasal

Read the full P21 guide →

Safety Note

Most compounds on this page are prescription drugs or research chemicals — not supplements. None of this content is medical advice: review each compound's full guide and safety note, respect WADA status if you compete, and consult a qualified clinician before making any health decision.

Frequently Asked Questions

Which nootropic peptide has the strongest evidence?

Semax: clinical-tagged BDNF/NGF modulation (a 1.4-fold BDNF increase and 3-fold exon III BDNF mRNA) and stroke-rehabilitation data. It is approved in Russia and research-only almost everywhere else.

Are Semax and Selank the same?

No — both are Russian-origin peptides, but Semax is a nootropic ACTH analogue and Selank is an anxiolytic with clinical-tagged anti-inflammatory effects (IL-1β, IL-6 and TNF-α decreases under stress).

Is cerebrolysin available without a prescription?

No — it is a prescription medication in several countries and requires medical supervision. It should never be treated as an over-the-counter nootropic.

How do dihexa and P21 compare?

Dihexa has a clinical-tagged synaptogenesis mechanism through HGF/c-Met but minimal human data and an extremely-potent safety flag; P21 neurogenesis and BDNF evidence is preclinical-tier. Both are early-stage.

Where Researchers Source Compounds

If you are exploring these compounds in a legitimate research setting, our partner store Peptide Hackers carries catalog-grade research peptides with third-party testing. We only link to suppliers we trust.

Visit Peptide Hackers →

Other Goals

Research purposes only. This ranking reflects the depth of published and catalogued evidence, not a recommendation to use any compound. Most peptides here are not approved for human use; always consult qualified medical professionals before making health decisions.